A total of 46 samples were collected from RT-PCR-confirmed COVID-19 patients at several time points ranging from 3 to 27 days post symptoms onset, and the levels of SARS-CoV-2-specific IgM and IgG antibody responses were determined using in-house ELISA that we recently developed and validated [5]. The gene discussed is CD40LG; the disease is COVID-19.